Detalles de la búsqueda
1.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study.
Lancet Oncol
; 24(5): 483-495, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080222
2.
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
Int J Cancer
; 149(2): 378-386, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33739449
3.
Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer.
Support Care Cancer
; 29(2): 733-739, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32447502
4.
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.
Gastric Cancer
; 22(4): 828-837, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30911859
5.
First Report of Dramatic Tumor Responses with Ramucirumab and Paclitaxel After Progression on Pembrolizumab in Two Cases of Metastatic Gastroesophageal Adenocarcinoma.
Oncologist
; 23(7): 840-843, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29674442
6.
Central nervous system relapse in patients with untreated HER2-positive esophageal or gastroesophageal junction adenocarcinoma.
Int J Cancer
; 139(7): 1626-31, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27198655
7.
HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma.
Cancer
; 120(3): 415-24, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24151090
8.
Life-threatening "hyper-progression" on immunotherapy revealed as pseudo-progression in DNA mismatch repair deficiency: a case report.
J Gastrointest Oncol
; 14(1): 435-441, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36915442
9.
Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer.
Front Oncol
; 13: 1081024, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36845682
10.
Understanding Suboptimal Response to Immune Checkpoint Inhibitors.
Adv Biol (Weinh)
; 7(4): e2101319, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35343107
11.
Impact of PD-1 Blockade in Nonresponders: Pitfalls and Promise.
Clin Cancer Res
; 28(15): 3173-3175, 2022 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671005
12.
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials.
JAMA Oncol
; 8(10): 1456-1465, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36006624
13.
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.
Clin Cancer Res
; 28(24): 5254-5262, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36228156
14.
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction.
Clin Cancer Res
; 28(14): 3021-3031, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35552651
15.
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group.
BMC Cancer
; 11: 176, 2011 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21586140
16.
Rapidly Evolving Treatment Landscape for Metastatic Esophagogastric Carcinoma: Review of Recent Data.
Onco Targets Ther
; 14: 4361-4381, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34385820
17.
Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis.
Front Oncol
; 11: 641044, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34568002
18.
Narrative review of pembrolizumab for the treatment of esophageal cancer: evidence and outlook.
Ann Transl Med
; 9(14): 1189, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430630
19.
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study.
Transl Oncol
; 14(2): 100973, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33338878
20.
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials.
JAMA Oncol
; 7(6): 895-902, 2021 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33792646